-
Leerink Partnrs Has Pessimistic View of XENE FY2024 Earnings
Source: Buzz FX / 15 Nov 2024 07:26:18 America/New_York
Leerink Partnrs Has Pessimistic View of XENE FY2024 Earnings Written by MarketBeat November 15, 2024 Share Link copied to clipboard. Bristol Myers Squibb’s big buys: $18.1 billion in 2 biotech deals Xenon Pharmaceuticals Inc.
Read more...